Covered recipient · General Payments record
GREGORY ALEXANDER DARNELL
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2022–2024
$1,008.24
- Reported across 70 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $474.96 | 37 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $220.99 | 22 |
| ABBVIE INC. | $191.44 | 11 |
| Lilly USA, LLC | $18.56 | 1 |
| Abbott Laboratories | $16.14 | 1 |
| GlaxoSmithKline, LLC. | $14.15 | 1 |
| Otsuka America Pharmaceutical, Inc. | $13.68 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (37)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $16.14 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125286042 | CMS |
| ABBVIE INC. | $21.95 | 01/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103601742 | CMS |
| ABBVIE INC. | $23.70 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103601744 | CMS |
| ABBVIE INC. | $20.32 | 02/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103601746 | CMS |
| ABBVIE INC. | $8.63 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103601748 | CMS |
| ABBVIE INC. | $21.33 | 07/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103601750 | CMS |
| ABBVIE INC. | $16.49 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103601752 | CMS |
| ABBVIE INC. | $10.40 | 07/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103601754 | CMS |
| ABBVIE INC. | $20.30 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103601756 | CMS |
| ABBVIE INC. | $22.70 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103601758 | CMS |
| ABBVIE INC. | $16.74 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103601760 | CMS |
| ABBVIE INC. | $8.88 | 11/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103601762 | CMS |
| GlaxoSmithKline, LLC. | $14.15 | 12/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116474647 | CMS |
| Lilly USA, LLC | $18.56 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134978882 | CMS |
| Novo Nordisk Inc | $8.34 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096883652 | CMS |
| Novo Nordisk Inc | $7.63 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097296661 | CMS |
| Novo Nordisk Inc | $7.83 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097470871 | CMS |
| Novo Nordisk Inc | $16.86 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097268977 | CMS |
| Novo Nordisk Inc | $7.46 | 05/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096918840 | CMS |
| Novo Nordisk Inc | $6.75 | 06/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097020978 | CMS |
| Novo Nordisk Inc | $6.78 | 07/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097788759 | CMS |
| Novo Nordisk Inc | $20.08 | 07/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096584546 | CMS |
| Novo Nordisk Inc | $1.00 | 08/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096822049 | CMS |
| Novo Nordisk Inc | $8.29 | 08/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097324983 | CMS |
| Novo Nordisk Inc | $8.47 | 08/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096586524 | CMS |
| Novo Nordisk Inc | $14.12 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096674997 | CMS |
| Novo Nordisk Inc | $0.51 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096902497 | CMS |
| Novo Nordisk Inc | $19.16 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097336952 | CMS |
| Novo Nordisk Inc | $7.75 | 09/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097407757 | CMS |
| Novo Nordisk Inc | $6.79 | 10/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097779257 | CMS |
| Novo Nordisk Inc | $7.43 | 10/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096839111 | CMS |
| Novo Nordisk Inc | $7.23 | 10/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097748030 | CMS |
| Novo Nordisk Inc | $7.20 | 11/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097747325 | CMS |
| Novo Nordisk Inc | $22.19 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097643952 | CMS |
| Novo Nordisk Inc | $9.04 | 12/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096946158 | CMS |
| Novo Nordisk Inc | $20.08 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097826235 | CMS |
| Otsuka America Pharmaceutical, Inc. | $13.68 | 05/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118882151 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.